“roche” Archives

in
Entry Author Date Location
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Warp Drive’s Odyssey Ends with a Buyout—By Revolution, Not Sanofi 10/16/18 San Francisco
Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs 10/15/18 Boston
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
Guardant Health’s IPO Tops Range, Raising $238M for Cancer Tests 10/04/18 San Francisco
FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize 10/01/18 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Another Precision Step for Roche as Ignyta Drug Heads to Regulators 09/24/18 San Francisco
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels In $90M 09/05/18 San Francisco
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Gregor Diagnostics Raises $900K to Develop New Prostate Cancer Test 07/10/18 Wisconsin
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
With Roche Data, Cancer Combos Post First Win Vs. Small Cell Lung Cancer 06/25/18 San Francisco
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine 06/19/18 Boston
Emulate Adds $36M to Expand “Organ Chip” Drug Research Technology 06/19/18 Boston
Bio Roundup: Wrapping ASCO, Dreaming IPO, Rebooting Axovant & More 06/08/18 National
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down 05/31/18 National
Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D 05/30/18 Texas
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results 05/29/18 San Francisco
Page 1 of 21 next page »